arrow
G

George Seed

The Institute of Cancer Research
H指数:28
被引数:6,576

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Corrigendum to “B7-H3 as a Therapeutic Target in Advanced Prostate Cancer” [European Urology 83 (2023) 224–238

勘误:“B7-H3 作为晚期前列腺癌的治疗靶点” [欧洲泌尿外科杂志 83 (2023) 224–238]

2026-08-070
OAAI
Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer

阐明靶向MCL1的分子分层单药及联合治疗策略,以治疗致命性前列腺癌

2025-10-080
OAAI
BCL2 expression is enriched in advanced prostate cancer with features of lineage plasticity
2024-09-170
OAAI
RNASEH2B loss and PARP inhibition in advanced prostate cancer
2024-06-040
OAAI
Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance

靶向髓系趋化逆转前列腺癌治疗耐药

Nature
IF48.5
2023-10-160
OAAI
Circulating tumor DNA (ctDNA) low pass whole genome sequencing (lpWGS) studies identify genomic alterations associating with taxane outcomes in prospective phase III taxane trials for metastatic castration resistant prostate cancer (mCRPC) sufferers
2023-10-010
OA
BCL2 expression is enriched in AR-independent advanced prostate cancer
2023-06-021
PRE
B7-H3 as a Therapeutic Target in Advanced Prostate Cancer (vol 83, pg 224, 2023)

B7-H3作为晚期前列腺癌的治疗靶点 (第83卷,224页,2023页)

2023-06-011
OA
Immune Biomarkers in Metastatic Castration-resistant Prostate Cancer

转移性去势抵抗性前列腺癌的免疫标志物

2022-12-0114
PRE
Elucidating Prostate Cancer Behaviour During Treatment via Low-pass Whole-genome Sequencing of Circulating Tumour DNA
2021-08-0131
OAAI
CD38 in Advanced Prostate Cancers

CD38在晚期前列腺癌中的作用

2021-06-0124
OA
Biomarkers Associating with PARP Inhibitor Benefit in Prostate Cancer in the TOPARP-B Trial

Toparp-b试验中与PARP抑制剂在前列腺癌中获益相关的生物标志物

2021-05-2799
OAAI
Advanced Prostate Cancer with ATM Loss: PARP and ATR Inhibitors
2021-02-0186
OAAI
Characterizing CDK12-Mutated Prostate Cancers
2021-01-1955
OAAI
Elucidating Durable Responses to Immune Checkpoint Inhibition
2020-10-012
PREAI
CDK12-mutated lethal prostate cancers: How hot are these tumors
2020-08-150
PRE
Genomics of lethal prostate cancer at diagnosis and castration resistance
2020-04-01206
PRE